Indications for single-dose activated charcoal administration in acute overdose

Current Opinion in Critical Care

Volumn 17, Issue 4, 2011, Pages 351-357

  Isbister, Geoffrey K ^a   Kumar, Venkata V Pavan ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

activated charcoal; decontamination; drug overdose; pharmacokinetic; poisoning

Indexed keywords

ACTIVATED CARBON;

AREA UNDER THE CURVE; HUMAN; INTOXICATION; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE;

ACUTE DISEASE; ANTIDOTES; AREA UNDER CURVE; CHARCOAL; DECONTAMINATION; HUMANS; OVERDOSE; POISONING; TIME FACTORS;

EID: 79960836895     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328348bf59     Document Type: Review

References (40)

1. Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:721-741.
2. Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43:61-87.
3. Buckley NA, Eddleston M. The revised position papers on gastric decontamination. Clin Toxicol (Phila) 2005; 43:129-130.
4. Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet 2008; 371: 579-587. (Pubitemid 351246703)
5. Eyer P, Eyer F. Is this the epitaph for multiple-dose activated charcoal? Lancet 2008; 371:538-539. (Pubitemid 351232016)
6. Cooper GM, Le Couteur DG, Richardson D, Buckley NA. A randomized clinical trial of activated charcoal for the routine management of oral drug overdose. QJM 2005; 98:655-660. (Pubitemid 41236094)
7. Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2006; 61:177-190. (Pubitemid 43382611)
8. Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007; 50:593-600.
9. Isbister GK, Friberg LE, Hackett LP, Duffull SB. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther 2007; 81:821-827. (Pubitemid 46788301)
10. Isbister GK, Duffull SB. Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal. Int Clin Psychopharmacol 2009; 24:174-180.
11. Kumar VV, Oscarsson S, Friberg LE, et al. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther 2009; 86:403-410.
12. Kumar VPK, Geoffrey KI, Duffull SB. The effect of decontamination procedures on pharmacodynamics of venlafaxine in overdose. Br J Clin Pharmacol 2011. doi: 10.1111/j.1365-2125.2011.03934.x.
13. Buckley NA, Whyte IM, O'Connell DL, Dawson AH. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol 1999; 37:753-757.
14. Page CB, Duffull SB, Whyte IM, Isbister GK. Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal. QJM 2009; 102:123-131.
15. Jurgens G, Hoegberg LC, Graudal NA. The effect of activated charcoal on drug exposure in healthy volunteers: a meta-analysis. Clin Pharmacol Ther 2009; 85:501-505.
16. Olson KR. Activated charcoal for acute poisoning: one toxicologist's journey. J Med Toxicol 2010; 6:190-198.
17. Gude AB, Hoegberg LC, Angelo HR, Christensen HR. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers. Basic Clin Pharmacol Toxicol 2010; 106:406-410.
18. Keranen T, Sorri A, Moilanen E, Ylitalo P. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. Arzneimittelforschung 2010; 60:421-426.
19. Wananukul W, Klaikleun S, Sriapha C, Tongpoo A. Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose. J Med Assoc Thai 2010; 93:1145-1149.
20. Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn 2005; 32:571-605. (Pubitemid 41738441)
21. Isbister GK, Friberg LE, Duffull SB. Application of pharmacokinetic- pharma-codynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 2006; 32:1060-1065. (Pubitemid 43952722)
22. Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharmacol Ther 1997; 61:275-291. (Pubitemid 27145429)
23. Merigian KS, Woodard M, Hedges JR, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990; 8:479-483.
24. Merigian KS, Blaho KE. Single-dose oral activated charcoal in the treatment of the self-poisoned patient: a prospective, randomized, controlled trial. Am J Ther 2002; 9:301-308.
25. Bond GR. The role of activated charcoal and gastric emptying in gastro-intestinal decontamination: a state-of-the-art review. Ann Emerg Med 2002; 39:273-286. (Pubitemid 34219641)
26. Underhill TJ, Greene MK, Dove AF. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Archives of Emergency Medicine 1990; 7:148-154.
27. Spiller HA, Sawyer TS. Impact of activated charcoal after acute acetaminophen overdoses treated with N-acetylcysteine. J Emerg Med 2007; 33:141-144. (Pubitemid 47199029)
28. Spiller HA, Winter ML, Klein-Schwartz W, Bangh SA. Efficacy of activated charcoal administered more than four hours after acetaminophen overdose. J Emerg Med 2006; 30:1-5. (Pubitemid 43129870)
29. Crome P, Adams R, Ali C, et al. Activated charcoal in tricyclic antidepressant poisoning: pilot controlled clinical trial. Hum Toxicol 1983; 2:205-209. (Pubitemid 13040468)
30. Bosse GM, Barefoot JA, Pfeifer MP, Rodgers GC. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med 1995; 13:203-209.
31. Hulten BA, Adams R, Askenasi R, et al. Activated charcoal in tricyclic antidepressant poisoning. Hum Toxicol 1988; 7:307-310.
32. Mohamed F, Sooriyarachchi MR, Senarathna L, et al. Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial. Clin Toxicol (Phila) 2007; 45:132-135. (Pubitemid 46280025)
33. Seger D. Single-dose activated charcoal: backup and reassess. J Toxicol Clin Toxicol 2004; 42:101-110. (Pubitemid 38450948)
34. Isbister GK, Downes F, Sibbritt D, et al. Aspiration pneumonitis in an overdose population: frequency, predictors, and outcomes. Crit Care Med 2004; 32:88-93. (Pubitemid 38125567)
35. Arnold TC, Willis BH, Xiao F, et al. Aspiration of activated charcoal elicits an increase in lung microvascular permeability. Journal of Toxicology -Clinical Toxicology 1999; 37:9-16.
36. Chan JC, Saranasuriya C, Waxman BP. Bezoar causing small bowel obstruction after repeated activated charcoal administration. Med J Aust 2005; 183:537. (Pubitemid 41723332)
37. Greene S, Harris C, Singer J. Gastrointestinal decontamination of the poisoned patient. Pediatr Emerg Care 2008; 24:176-186; quiz 87-9. (Pubitemid 351416877)
38. Bailey B. Gastrointestinal decontamination triangle. Clin Toxicol (Phila) 2005; 43:59-60.
39. Alaspaa AO, Kuisma MJ, Hoppu K, Neuvonen PJ. Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 45:207-212.
40. Isbister GK. How do we use drug concentration data to improve the treatment of overdose patients? Ther Drug Monit 2010; 32:300-304.